Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Finasteride reduces prostate bleeding by affecting blood vessel growth.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Loss of keratin K2 causes skin problems and inflammation.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Finasteride reverses early hair loss and promotes growth.

Hoxc13 is linked to seasonal hair growth in Cashmere goats and is affected by melatonin.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Hair color and length affect metabolite profiles in hair, so they should be considered in hair analysis.

Carboxytherapy can improve skin conditions with few side effects, but results may vary and are not guaranteed.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Hormones significantly affect women's sexual function, and more research is needed to improve treatments for sexual dysfunction with minimal side effects.

Hyaluronic acid and versican are important for skin healing and hair growth and might help in regenerative medicine.

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Lack of certain cells causes abnormal nipple development and nursing failure.

Alopecia from CDK 4/6 inhibitors worsens quality of life in breast cancer patients.

Dietary interventions improved hair density and reduced dandruff by balancing scalp microbiota and reducing inflammation.

GLP-1 agonists may help treat certain skin conditions.

Seborrheic alopecia in adolescents is linked to hormones, stress, and lifestyle, and can be treated with medication, lifestyle changes, and therapy.

Herbal treatments can help manage PCOS symptoms.

Newly born mesenchymal cells quickly spread out in response to tissue tension during early development.

Researchers created a skin graft that senses blood glucose and could treat diabetes using CRISPR-edited stem cells.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.